Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

International Survey on the Use of Complementary and Alternative Medicines for Common Toxicities of Radiation Therapy.

Lee A, Kuczmarska-Haas A, Macomber MW, Woo K, Freese C, Morris ZS.

Adv Radiat Oncol. 2018 Oct 5;4(1):134-141. doi: 10.1016/j.adro.2018.09.012. eCollection 2019 Jan-Mar.

2.

Brachytherapy Training Survey of Radiation Oncology Residents.

Marcrom SR, Kahn JM, Colbert LE, Freese CM, Doke KN, Yang JC, Yashar CM, Luu M, Kamrava M.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):557-560. doi: 10.1016/j.ijrobp.2018.10.023. Epub 2018 Oct 26.

PMID:
30612963
3.

The absolute volume of PET-defined, active bone marrow spared predicts for high grade hematologic toxicity in cervical cancer patients undergoing chemoradiation.

Zhou YM, Freese C, Meier T, Go D, Khullar K, Sudhoff M, Lamba M, Kharofa J.

Clin Transl Oncol. 2018 Jun;20(6):713-718. doi: 10.1007/s12094-017-1771-6. Epub 2017 Oct 26.

PMID:
29076030
4.

The volume of PET-defined, active bone marrow spared predicts acute hematologic toxicities in anal cancer patients receiving concurrent chemoradiotherapy.

Freese C, Sudhoff M, Lewis L, Lamba M, Kharofa J.

Acta Oncol. 2018 May;57(5):683-686. doi: 10.1080/0284186X.2017.1377847. Epub 2017 Sep 13. No abstract available.

PMID:
28903619
5.

Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.

Freese C, Takiar V, Fouladi M, DeWire M, Breneman J, Pater L.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):86-92. doi: 10.1016/j.prro.2016.11.005. Epub 2016 Nov 23. Review.

PMID:
28274399

Supplemental Content

Loading ...
Support Center